Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05662839
Other study ID # CFTSp203
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2023
Est. completion date January 2024

Study information

Verified date December 2022
Source The Christie NHS Foundation Trust
Contact shira Baram
Phone 07970271667
Email shira.baram@nhs.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In an attempt to reduce patient flow into the hospital we are going to assess the use of penile cytological brushings and dermoscopy in diagnosing cancer or non-cancer conditions of the penis.


Description:

Currently the standard of care pathway for all patients suspected of having penile cancer involves the need for a penile biopsy under local (LA) or general anaesthetic (GA). We hope to assess the feasibility of cytololgical brushings and the patient experience of the use of such a technique. Additionally, we will make initial comparison on the concordance between cytological brushing and dermoscope photo vs actual biopsy only. Importantly for this study, all patients will be offered standard of care: a biopsy under LA or GA. The additional procedures of the cytological brushing and dermoscope photo will be done in an out-patient clinic setting (with no anaesthetic). If it can be shown that the inclusion of the cytological brushing and dermoscope photo have comparative results over current standard of care histological biopsy, this will provide sufficient evidence to expand this study to acquire more data.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date January 2024
Est. primary completion date January 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. All patients requiring either diagnostic biopsy or WLE (wide local excision) of a lesion of the penis 2. Age > 18 years 3. Written informed consent provided by the patient 4. Subject has been scheduled for surgical intervention, with a biopsy procedure being a part of the surgical plan Exclusion Criteria: 1. Subject is unfit for surgery upon surgeon's assessment. 2. Unable to provide consent 3. Those with terminal disease 4. Those with palpable lymph nodes 5. Other coincident cancers 6. Previous radiotherapy treatment to the penis, bladder, prostate, anus 7. Subject is deprived of liberty or under guardianship 8. Subject is not able to follow and understand the procedures of the study due to mental state or other reasons

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cytological Brushing
All participants will undergo cytological brushing to collect cell samples for analysis

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
The Christie NHS Foundation Trust

Outcome

Type Measure Description Time frame Safety issue
Primary Does cytology results compare equally with standard histological biopsy for detecting cancer Concordance of cytology vs Histopathology i.e. is the cytology assessment equal to histopathology results when detecting cancer Through study completion, expected to be 12 months
Primary Does the use of dermoscopy photography enable us to identify abnormal cellular changes that compare equally to the results obtained with standard histological biopsy. Concordance of dermoscopy vs Histopathology in detecting cancer i.e. does the use of dermoscopy photographs enable us to identify cancer and compare equally to results obtained by histopathology Through study completion, expected to be 12 months
Secondary Patient satisfaction with cytological brushing diagnostic method being tested All patients on study will be asked their views on the cytology brushing technique being used to gauge their satisfaction and experience of the new diagnostic method being tested Through study completion, expected to be 12 months
See also
  Status Clinical Trial Phase
Completed NCT03686332 - PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study Phase 2
Completed NCT05518201 - Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old Phase 1
Recruiting NCT04708470 - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers Phase 1/Phase 2
Active, not recruiting NCT04357873 - Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations Phase 2
Terminated NCT00058448 - S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED) Phase 2
Recruiting NCT02817958 - Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis Phase 2
Completed NCT02280811 - T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers Phase 2
Recruiting NCT02994758 - Development of Diagnostics and Treatment of Urological Cancers N/A
Completed NCT00019110 - Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer Phase 1
Completed NCT04574427 - INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue
Recruiting NCT02012699 - Integrated Cancer Repository for Cancer Research
Recruiting NCT05946993 - Linking In With Advice and Supports for Men Impacted by Metastatic Cancer N/A
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Recruiting NCT05686226 - E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers Phase 2
Completed NCT05376202 - Image Guided Penile Cancer Surgery Phase 1
Recruiting NCT05264337 - Lymphedema After Urologic Surgery
Recruiting NCT03774901 - Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma Phase 2
Completed NCT01209325 - Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males Phase 2
Recruiting NCT05592639 - VideoEndoscopic Radical Inguinal Lymphadenectomy for Penile Cancer N/A
Completed NCT00066391 - Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer Phase 2